Clarus Therapeutics Files for Chapter 11
Clarus Therapeutics, together with its wholly-owned subsidiary Clarus Therapeutics, has filed voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
September 6, 2022
Clarus Therapeutics | Dr. Robert Dudley | Goodwin Procter | Lawrence Perkins | Potter Anderson & Corroon | Raymond James & Associates | Sierra Constellation Partners
Ian Koplin